Ault Global Holdings Announces $10 Million Investment in Alzamend Neuro

16 Mar, 2021

Ault Global Holdings Announces $10 Million Investment in Alzamend Neuro
Photo by Macau Photo Agency on Unsplash

– Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company, announced today that its wholly owned subsidiary, Digital Power Lending, LLC, has entered into a securities purchase agreement with Alzamend Neuro, Inc. to invest $10m in Alzamend common stock and warrants.
– Alzamend Neuro, Inc. is an early stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.
– Alzamend currently has two product candidates, aiming to bring treatments or cures for Alzheimer’s disease and other neurodegenerative diseases and psychiatric disorders to market at a reasonable cost as quickly as possible.

Biotechnology Health Care Health Diagnostics Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: